Speakers:

Olga Klibanov, PharmD, BCPS
Professor of Pharmacy
Wingate University School of Pharmacy

Learning Objectives:

1. Describe the epidemiology, transmission, pathogenesis, and complications associated with chronic HCV.

2. Highlight patient populations that should be screened for chronic HCV

3. Review the common adverse events, DDIs, and contraindications with anti-HCV agents

4. Describe the genotypic activity of novel anti-HCV oral agents and their utility in the different HCV-infected patient types

5. Highlight the recommended treatment regimens for patients with HCV based on the most updated guidelines

Continuing Education:
Correspondence (1 hr)